The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-Butyl-8-(3,4,5-trimethoxy-benzenesulfonyl)-9H-purin-6-ylamine ID: ALA190654
Cas Number: 827302-63-6
PubChem CID: 44399994
Max Phase: Preclinical
Molecular Formula: C18H23N5O5S
Molecular Weight: 421.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCn1c(S(=O)(=O)c2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21
Standard InChI: InChI=1S/C18H23N5O5S/c1-5-6-7-23-17-14(16(19)20-10-21-17)22-18(23)29(24,25)11-8-12(26-2)15(28-4)13(9-11)27-3/h8-10H,5-7H2,1-4H3,(H2,19,20,21)
Standard InChI Key: HCIBJWRRCCOAEZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
3.3629 -8.0765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3616 -8.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0746 -9.3171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0727 -7.6637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7909 -8.0725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7961 -8.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5886 -9.1563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0733 -8.4804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5802 -7.8107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0688 -6.8386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8984 -8.4752 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.7190 -8.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8935 -7.6502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9076 -9.3002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8484 -9.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3001 -10.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5599 -11.3390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0116 -11.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1314 -9.1815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9513 -9.1773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3584 -8.4639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9398 -7.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1213 -7.7607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3451 -7.0404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9262 -6.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1808 -8.4603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5885 -7.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3646 -9.8871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1896 -9.8830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 14 2 0
1 2 2 0
7 15 1 0
5 4 2 0
15 16 1 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 1 0
8 9 2 0
12 19 2 0
9 5 1 0
19 20 1 0
4 1 1 0
20 21 2 0
4 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 12 1 0
8 11 1 0
24 25 1 0
22 24 1 0
11 12 1 0
2 3 1 0
26 27 1 0
21 26 1 0
11 13 2 0
3 6 2 0
28 29 1 0
20 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 421.48Molecular Weight (Monoisotopic): 421.1420AlogP: 2.07#Rotatable Bonds: 8Polar Surface Area: 131.45Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.22CX LogP: 2.18CX LogD: 2.18Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.58Np Likeness Score: -0.59
References 1. Llauger L, He H, Kim J, Aguirre J, Rosen N, Peters U, Davies P, Chiosis G.. (2005) Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90., 48 (8): [PMID:15828828 ] [10.1021/jm049012b ] 2. Gundla R, Kazemi R, Sanam R, Muttineni R, Sarma JA, Dayam R, Neamati N.. (2008) Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach., 51 (12): [PMID:18500794 ] [10.1021/jm7013875 ]